FDA Approval Summary: Sonidegib-Response

被引：4
|
作者：
Shord, Stacy S. [1 ]
Casey, Denise [1 ]
Zhao, Hong [1 ]
Demko, Suzanne [1 ]
Keegan, Patricia [1 ]
Pazdur, Richard [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源：
CLINICAL CANCER RESEARCH | 2017年 / 23卷 / 19期
关键词：
DRUGS;
D O I：
10.1158/1078-0432.CCR-17-2135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5994 / 5994
页数：1
相关论文
共 50 条
  • [1] FDA Approval Summary: Sonidegib-Letter
    Gyawali, Bishal
    Ando, Yuichi
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5993 - 5993
  • [2] FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma
    Casey, Denise
    Demko, Suzanne
    Shord, Stacy
    Zhao, Hong
    Chen, Huanyu
    He, Kun
    Putman, Alexander
    Helms, Whitney
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2377 - 2381
  • [3] Summary of the US FDA Approval of Belatacept
    Archdeacon, P.
    Dixon, C.
    Belen, O.
    Albrecht, R.
    Meyer, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (03) : 554 - 562
  • [4] FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response
    Fallah, Jaleh
    Weinstock, Chana
    Mehta, Gautam U.
    Brave, Michael H.
    Pierce, William F.
    Pazdur, Richard
    Nair, Abhilasha
    Suzman, Daniel L.
    Amiri-Kordestani, Laleh
    CLINICAL CANCER RESEARCH, 2023, 29 (03) : 685 - 685
  • [5] FDA Approval Summary: Ramucirumab for Gastric Cancer
    Casak, Sandra J.
    Fashoyin-Aje, Ibilola
    Lemery, Steven J.
    Zhang, Lillian
    Jin, Runyan
    Li, Hongshan
    Zhao, Liang
    Zhao, Hong
    Zhang, Hui
    Chen, Huanyu
    He, Kun
    Dougherty, Michele
    Novak, Rachel
    Kennett, Sarah
    Khasar, Sachia
    Helms, Whitney
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2015, 21 (15) : 3372 - 3376
  • [6] FDA Approval Summary: Selumetinib for Plexiform Neurofibroma
    Casey, Denise
    Demko, Suzanne
    Sinha, Arup
    Mishra-Kalyani, Pallavi S.
    Shen, Yuan-Li
    Khasar, Sachia
    Goheer, M. Anwar
    Helms, Whitney S.
    Pan, Lili
    Xu, Yuan
    Fan, Jianghong
    Leong, Ruby
    Liu, Jiang
    Yang, Yuching
    Windsor, Katherine
    Ou, Mei
    Stephens, Olen
    Oh, Byeongtaek
    Reaman, Gregory H.
    Nair, Abhilasha
    Shord, Stacy S.
    Bhatnagar, Vishal
    Daniels, Selena R.
    Sickafuse, Sharon
    Goldberg, Kirsten B.
    Theoret, Marc R.
    Pazdur, Richard
    Singh, Harpreet
    CLINICAL CANCER RESEARCH, 2021, 27 (15) : 4142 - 4146
  • [7] FDA drug approval summary:: Panitumumab (Vectibix™)
    Giusti, Ruthann M.
    Shastri, Kaushikkumar A.
    Cohen, Martin H.
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2007, 12 (05): : 577 - 583
  • [8] FDA Approval Summary: TAS-102
    Marcus, Leigh
    Lemery, Steven J.
    Khasar, Sachia
    Wearne, Emily
    Helms, Whitney S.
    Yuan, Weishi
    He, Kun
    Cao, Xianhua
    Yu, Jingyu
    Zhao, Hong
    Wang, Yaning
    Stephens, Olen
    Englund, Erika
    Agarwal, Rajiv
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 2924 - 2927
  • [9] FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer
    Duke, Elizabeth S.
    Barone, Amy K.
    Chatterjee, Somak
    Mishra-Kalyani, Pallavi S.
    Shen, Yuan-Li
    Isikwei, Emasenyie
    Zhao, Hong
    Bi, Youwei
    Liu, Jiang
    Rahman, Nam Atiqur
    Wearne, Emily
    Leighton, John K.
    Stephenson, Maritsa
    Ojofeitimi, Idara
    Scepura, Barbara
    Nair, Abhilasha
    Pazdur, Richard
    Beaver, Julia A.
    Singh, Harpreet
    CLINICAL CANCER RESEARCH, 2022, 28 (19) : 4173 - 4177
  • [10] FDA drug approval summary:: Erlotinib (Tarceva®) tablets
    Cohen, MH
    Johnson, JR
    Chen, YF
    Sridhara, R
    Pazdur, R
    ONCOLOGIST, 2005, 10 (07): : 461 - 466
12345